Invasive pneumococcal infections

  1.  For individuals aged 65 and over
    - who have never been vaccinated before: Administration of a single dose of the PCV20 vaccine. No boosters are required.
    - who have previously been vaccinated with the PPV23 vaccine: Administration of a single dose of the PCV20 vaccine at least one year after the PPV23 vaccine was administered. No boosters are required.
    - who have previously been vaccinated with the PCV13 vaccine: Administration of a single dose of the PPV23 vaccine at least two months after the PCV13 vaccine. No boosters are required.
  2. For immunosuppressed individuals aged 18 and over, in whom there is a risk of complications or severe pneumococcal infection
    - who have never been vaccinated before: Administration of a single dose of the PCV20 vaccine, with a PPV23 vaccine booster every five years.
    - who have previously been vaccinated with the PPV23 vaccine: Administration of a single dose of the PCV20 vaccine at least one year after the PPV23 vaccine, with a PPV23 vaccine booster every five years.
    - who have been previously vaccinated with the PCV13 vaccine: Administration of a single dose of the PPV23 vaccine at least two months after the PCV13 vaccine, with a PPV23 vaccine booster every five years.

 

  • 2019/12 - Recommendations (Pdf, 778 Kb) on the vaccination of babies born prematurely

    The Superior Council of Infectious Diseases (CSMI) recommends vaccinating babies born prematurely (i.e. before 37 weeks of amenorrhoea) as follows: 1) depending on the child's age 2) by supplementing the universal vaccination schedule with an additional dose: 2.1.) of pneumococcal conjugate vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 33 weeks, or < 1,500 g; 2.2.) of hepatitis B vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 2,000 g; 3) by supplementing the universal vaccination schedule with: 3.1.) a seasonal influenza vaccine dose, for premature babies < 33 weeks, for the first two winter seasons; 3.2.) RSV (respiratory syncytial virus) immunisation, for premature babies who are at risk during the winter season. In addition, the CSMI recommends checking and updating the vaccination status of those in the premature baby's family circle – especially as regards whooping cough – and vaccinating them against seasonal influenza during the child's first two winters.
 
  • 2016/09 - Superior Council of Infectious Diseases's opinion (Pdf, 528 Kb) on universal pneumococcal vaccination: 10- or 13-valent vaccine?

    The purchase order agreement for the pneumococcal conjugate vaccine for children should be renewed, and the CSMI has been asked to issue a new opinion on the two vaccines that are available on the market.

 

  • 2015/07 - Specific recommendations (Pdf, 271 Kb) for children under the age of 18 who are at specific risk of contracting invasive pneumococcal infections

 

  • 2011/02 - Recommendations (Pdf, 105 Kb) on the universal vaccination of infants and children against invasive Streptococcus pneumoniae infections

    The CSMI's Communicable Diseases Section (Section des maladies transmissibles) has updated its recommendations on the universal immunisation of infants and children against invasive Streptococcus pneumoniae infections. Essentially, the CSMI recommends switching from a 3+1 schedule to a 2+1 schedule, except for children at specific risk.

Last update